ITGR
Integer Holdings·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ITGR
Integer Holdings Corporation
A leading medical device outsource manufacturer
Healthcare Equipment and Supplies
--
09/29/2000
New York Stock Exchange
11,000
12-31
Common stock
5830 Granite Parkway, Suite 1150, Plano, Texas 75024
--
Integer Holdings Corporation invented the first successful implantable cardiac pacemaker and was founded in 1970. The Company is a Delaware corporation incorporated in 1997. In 2000, the company IPO new shares. The Company has established two reporting divisions: Greitberg Medical and Electrochemical Solutions (" Electrochemistry "). The Company's customers include large multinational original equipment manufacturers (" OEMs "). The Gritebo Medical Division designs and manufactures medical devices and components, primarily for the cardiac rhythm management (" CRM "), neuromodulation, vascular access and orthopedic markets. In addition, Great Power Medical provides value-added assembly and design engineering services for products that incorporate Great Power Medical components. As a result, its strategy was put in place three years ago, and Great Medical now provides customers with complete medical devices, including design, development, manufacturing, regulatory submissions and support for global distribution. The Medical Devices strategy is to facilitate the implementation and utilization of Gritebo Medical and Electrochemistry through the Salt Lake Group in the company's core markets of component technologies: cardiovascular, neuromodulation and orthopedics. The Salt Lake Group designs and develops medical devices, which are manufactured by Great Medical.
Earnings Call
Company Financials
EPS
ITGR has released its 2025 Q3 earnings. EPS was reported at 1.79, versus the expected 1.68, beating expectations. The chart below visualizes how ITGR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ITGR has released its 2025 Q3 earnings report, with revenue of 467.69M, reflecting a YoY change of 8.41%, and net profit of 39.68M, showing a YoY change of 11.96%. The Sankey diagram below clearly presents ITGR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available

